Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
暂无分享,去创建一个
R. Wunderink | K. Kaye | J. Solomkin | G. Rahav | M. Bassetti | A. Mathers | E. Giamarellos‐Bourboulis | M. Dudley | G. Daikos | O. Cornely | T. Felton | J. Bishara | F. Menichetti | Shu Zhang | I. Oren | J. Loutit | E. Kwak | O. Lomovskaya | T. Bhowmick | David A Griffith | E. Alexander | J. Vázquez | M. J. L. Furst